Physician profile
Aaron Burrows
NPI 1366491367
$973.50
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $269 · 2021: $292 · 2022: $132 · 2023: $18.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $395.21 | 2019-2022 | |
| Gilead Sciences, INC. | $175.77 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $125.75 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $74.45 | 2020-2022 | |
| Ferring Pharmaceuticals INC. | $34.54 | 2020 | |
| Celgene Corporation | $32.54 | 2021-2022 | |
| Boston Scientific Corporation | $18.80 | 2023 | |
| Medtronic, INC. | $17.76 | 2021 | |
| Nestle Healthcare Nutrition INC. | $17.56 | 2022 | |
| Redhill Biopharma INC. | $15.44 | 2021 | |
| Qol Medical, LLC | $14.92 | 2019 | |
| Alfasigma USA, INC. | $13.69 | 2020 | |
| Merck Sharp & Dohme LLC | $13.26 | 2019 | |
| Janssen Biotech, INC. | $12.83 | 2019 | |
| Endo Pharmaceuticals INC. | $10.98 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Burrows listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.